One of the stocks that could be on the radars of many investors today is the Adma Biologics Inc (NASDAQ:ADMA) stock. Yesterday, the company announced its financial results for the second fiscal quarter on Wednesday and since then the stock has been in focus.
It has made an upward move in the premarket trading period and already gone up by as much as 4%. Although it remains to be seen if the stock can add to its gains through the rest of the day, it might be the right time for investors to take a closer look at Adma’s financial results.
However, it is interesting to note that the company actually reported a loss of as much as $18.9 million and despite that the investors seem undeterred about the Adma stock. Adma, which is based out of Ramsey in New Jersey, also pointed out that it suffered a loss of 15 cents a share. The reason why the stock rallied despite the loss is that the company actually met the expectations of Wall Street analysts. The average projections with regards to the loss per share from three analysts stood at 15 cents a share. Hence, the rally in the stock is perhaps not a surprise.
